Abstract
Introduction
Anxiety and depression are common in elderly people diagnosed with Alzheimer's disease (AD) occurring in about 25% to 70% of patients (1) (2) (3) (4) (5) (6) (7) (8) . Anxiety and depression are known to have an influence on cognition in non demented elderly people (9) . Generally, studies on depression show a negative effect on cognitive decline (10) (11) (12) (13) . Some studies on the association between anxiety symptoms and cognition also found this negative effect (13) .
However, previous research in a population based cohort of elderly people, showed that mild anxiety symptoms enhanced cognitive abilities while severe anxiety symptoms were associated with a decline in cognitive abilities (9) . A possible theoretical framework for the association between anxiety and depression on one side and cognitive decline one the other is based on the glucocorticoïd cascade hypothesis (14) (15) . This hypothesis indicates that psychological distress may lead to excessive levels of glucocorticoïds (16) . Especially the hippocampus is highly sensitive to these stress hormones, and plays a critical role in learning and memory. Therefore, exposure to long term high levels of the stress hormones might cause impairment of memory function (17) (18) (19) . In patients with AD the hippocampus is already atrophied, psychological stress such as anxiety and depression might cause further hippocampal damage (16) . This might lead to an accelerated decline of memory function in AD patients. Because variation and decline of memory function can be measured in patients with early stage AD, an influence of anxiety and depression on memory function is most likely to be detected in patients in this stage of AD. Therefore the present study will investigate whether symptoms of anxiety and depression influence decline of memory function in elderly people diagnosed with early stage AD.
Method
Sample A study sample of 66 patients with early stage AD was collected in several general hospitals and mental health care institutes in the Netherlands. Patients were included when AD was recently diagnosed by a clinician, and when they had a score of 1 on the Clinical Dementia Rating (CDR (20) ). A first-degree relative or caregiver in close contact with the patient had to be available to provide information about the patient. Anxiety disorders, according to the DSM-IV criteria (26) , were diagnosed by means of the Composite International Diagnostic Interview (CIDI (27) ). The 6-months prevalence rates for specific phobia, social phobia, agoraphobia without panic, panic disorder without agoraphobia, panic disorder with agoraphobia, and generalized anxiety disorder (GAD) were included in the present study. Depressive disorders according to DSM-IV criteria (26) , were diagnosed by using the National Institute of Mental Health Diagnostic Interview Schedule (DIS (30) ). For this study 6-month prevalence rate of major depression were included.
Confounders
Possible confounding variables that may be associated with both cognitive decline and anxiety and depression include socio-demographics, alcohol consumption, cardiovascular disease, diabetes mellitus and the use of medication. All information was cross-checked with information provided by the relative or care-giver of the patient.
The following socio-demographic variables were included: age and level of education. With respect to memory function; the mean learning score declined between the two measurements (p = 0.04), but no significant decline was found on the recall score (p= 0.15). We found no association between depressive disorders and decline in memory function (results not shown), and were not able to establish a possible association between anxiety disorders and decline in memory function due to the low prevalence of anxiety disorders.
Discussion
The present study investigated whether psychological distress such as anxiety and depressive symptoms would result in an accelerated decline of memory function in AD patients. Against our expectations, it was found that higher levels of anxiety symptoms were associated with less decline of memory function, specifically the learning phase, over a one-year period, whereas depressive symptoms were not related to decline of memory function. In our sample of early stage AD patients, levels of anxiety and depressive symptoms were low. These mild levels of anxiety and depressive symptoms might not have caused the distress we assumed and therefore the hypothesized damaging effect of hypersecretion of stress hormones could not be established. Nevertheless, our findings are interesting and fit previous cross-sectional research in a population-based sample of elderly persons ( (9), which also showed that subclinical levels of anxiety symptoms enhance cognitive performance, while severe anxiety symptoms were associated with lesser cognitive abilities. The enhanced memory function as a consequence of mild anxiety symptoms is probably caused by an arousing function that services performance (33) . According to our results, this mechanism is also applicable to The findings have to be placed in the context of the strengths and limitations of this study. Strengths of the current study are that elderly people diagnosed with early stage AD are followed over a period of one year providing data on decline of memory function and anxiety and depressive symptoms and confounding variables. However there are also limitations.
Firstly, studying enough AD patients with serious distress will acquire a much larger study population. The second limitation is that the performance on the recall of the AVLT might have suffered from a floor effect causing the lack of association between anxiety or depression and decline of memory performance on this component. The patients scored on average 0.59 at baseline and 0.28 at the follow up measurement even though the scale ranges from 0 to 8.
Concluding, symptoms of anxiety and depression generally seem to be mild in early AD patients, and do not seem to effect decline of memory function in patients diagnosed with AD. On the contrary we found anxiety symptoms were associated with less decline of memory function.
